An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-8 | Issue-06
Assessment of Sympathetic Function Test in Breast Cancer Patients after Chemotherapy Treatment (Anthracycline Group of Drug Particular Doxorubicin)
Ms. Islam Khan, Dr. Raghuveer Choudhary, Dr. Kamla Choudhary, Dr. Vihan Chawdhary, Ms. Nikita Jain
Published: June 10, 2020 | 177 162
DOI: 10.36347/sjams.2020.v08i06.005
Pages: 1411-1414
Breast cancer, one of the most common malignancies affecting woman worldwide. Treatment of breast cancer by Anthracycline group of drug which are the most effective anticancer treatments ever develops. However, cardio toxicity is a well-recognized side effect of anthracycline treatment and can cause heart failure. The aim of the study was to Assessment of sympathetic function test in breast cancer patients after chemotherapy treatment. We enroll 125 symptomatic breast cancer patients (Before and after chemotherapy treatment) who treated with anthracycline group of drug. To assess the Sympathetic functions CANWin device was used. The result showed that ΔSBP after standing is significantly increased while ΔDBP after SHP (SUSTAIN HAND GRIP TEST) significantly decreased in breast cancer patients after chemotherapy (Anthracycline) treatment.